You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : HEALTHCARE EQUIPMENT & SUPPLIES
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. NATERA INC

Natera Inc XNAS: NTRA

Natera Inc Live Share Price Today, Share Analysis and Chart

Momentum Trap
Download real time

150.87 4.59 (3.14%)

81.49% Gain from 52W Low

2.2M XNAS Volume

XNAS 19 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share

Natera Inc Key Metrics

Select

Market Capitalization

High in industry
20,395.5

PE TTM

Negative PE TTM
-107.1

PEG TTM

Negative PEG TTM
-1.9

Price to Book

High in industry
17.1

Institutional holding current Qtr %

Below industry Median
92.9

Revenue Growth Qtr YoY %

High in industry
53

Operating Revenue growth TTM %

High in industry
56.7

Net Profit Qtr Growth YoY %

Below industry Median
31.1

Net Profit TTM Growth %

High in industry
56.2

Operating Profit Margin Qtr %

Negative Operating Profit Margin Qtr %
-13.6

Operating Profit Margin TTM %

Negative Operating Profit Margin TTM %
-13.1

Piotroski Score

Below industry Median
3

Rel Perf vs Sector quarter%

-5.7

ROE Annual %

Negative ROE Annual %
-19.4

RoA Annual %

Negative RoA Annual %
-12.3
All financials are in USD Million and price data in USD
VIEW MORE
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Expensive Valuation
4.0 / 100
Momentum Score
Technically Neutral
56.2 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
188
1Yr Price target upside is 25%
21 analysts

22

S

7

W

1

O

1

T

SWOT Analysis

Check P/E Buy Sell Zone

This stock has negative PE


Natera Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '2601k2k3kActual RevenueAvg. Estimate
Hit

Natera Inc's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

Current EPS
-1.5
Avg. Estimate
-2.1
Low Estimate
-2.7
High Estimate
-1.8
Current EPS
Avg. Estimate
Miss

EPS is expected to reduce by 39.2% in FY25

Consensus Recommendation

21 ANALYST Recommendations
BUY

Created with Highcharts 7.2.21Sell8Buy12Strong Buy

The consensus recommendation from 21 analysts for Natera Inc is BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Natera Inc Stock Analysis

Natera Inc stock analysis with key metrics, changes, and trends.

Natera Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$1,696.91 M56.75%positive

Annual Revenue rose 56.75%, in the last year to $1,696.91 M. Its sector's average revenue growth for the last fiscal year was 8.73%.

Annual Net Profit$190.43 M56.2%positive

Annual Net Profit rose 56.2% in the last year to $190.43 M. Its sector's average net profit growth for the last fiscal year was 3.61%.

Price to Earning Ratio-107.1-negative

Price to Earning Ratio is -107.1, which is negative.

Stock Price$150.8767.41%positive

Stock Price rose 67.41% and outperformed its sector by 59.75% in the past year.

Quarterly Revenue$476.06 M53.02%positive

Quarterly Revenue rose 53.02% YoY to $476.06 M. Its sector's average revenue growth YoY for the quarter was 8.58%.

Quarterly Net profit$53.77 M31.09%positive

Quarterly Net profit rose 31.09% YoY to $53.77 M. Its sector's average net profit growth YoY for the quarter was 27.3%.

Debt to Equity Ratio0.16-positive

Debt to Equity Ratio of 0.16 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)-19.42 %-19.42%negative

Return on Equity(ROE) for the last financial year was -19.42%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding74.26 %-0.11%negative

Mutual Fund Holding decreased by 0.11% in the last quarter to 74.26.

Promoter Share Holding4.59 %0.13%positive

Promoter Share Holding increased by 0.13% in the most recent quarter to 4.59%.

Interest Coverage Ratio-16.76-negative

Interest Coverage Ratio is -16.76, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding92.92 %0%neutral

Institutional Holding remained the same in the last quarter at 92.92%.

VIEW LESS


Loading data..

Natera Inc - Company Profile

What does Natera Inc do?

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Natera Inc Management structure

All Gross Remunerations are in USD
Mr. Michael Brophy
Chief Financial Officer and Principal Accounting Officer
-
2024
Gross Remuneration
Year
Mr. Steven Leonard Chapman
Director, Chief Executive Officer and Co-President
-
2024
Gross Remuneration
Year

Natera Inc Board of directors

All Gross Remunerations are in USD
Dr. Monica Bertagnolli, M.D.
Independent Director
-
2025
Gross Remuneration
Year

Natera Inc FAQ

How is Natera Inc today?
Natera Inc today is trading in the green, and is up by 3.14% at 150.87.
Natera Inc is currently trading up 3.14% on an intraday basis. In the past week the stock rose 7.75%. stock has been down -2.79% in the past quarter and rose 67.41% in the past year. You can view this in the overview section.